Cstone pharma aktie
WebApr 6, 2024 · CStone Pharmaceuticals Announces NMPA Accepts the Supplemental Biologics License Application for Sugemalimab as First-Line Treatment for Esophageal Squamous Cell Carcinoma CI Summary WebMOBVISTA INC. : Vorstellung des Unternehmens MOBVISTA INC., Aktionäre, Vorstände und Berufsbeschreibung, Finanzstärkerating, offizielle Mitteilungen, Kontaktdaten ...
Cstone pharma aktie
Did you know?
WebGet the latest CStone Pharmaceuticals (2616) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and …
WebApr 6, 2024 · CStone Pharma annonce que les résultats d'une étude sur le traitement du lymphome ont é.. 03/31: CStone Pharmaceuticals annonce la publication des résultats de l'étude GEMSTONE-201 sur.. 03/24: CStone Pharmaceuticals attribue des unités d'actions restreintes et des options sur act.. 03/20 WebOct 12, 2024 · Oktober 2024 /PRNewswire/ -- CStone Pharmaceuticals („CStone" HKEX: 2616) gab heute den Abschluss der Aktienzeichnungsvereinbarung bekannt, durch die …
WebCstone Pharmaceuticals Co. Ltd. is an investment holding company, which engages in the research and development of complex biopharmaceutical products and sale of … WebApr 23, 2024 · CStone Pharmaceuticals (HKEX: 2616) is a biopharmaceutical company focused on developing and commercializing innovative immuno-oncology and precision medicines to address the unmet medical needs ...
WebPipeline-CStone Pharmaceuticals. We focus on immuno-oncology and precision medicine with a well-balanced oncology portfolio of 15 innovative assets. Currently, CStone has received 10 NDA approvals for its 4 …
WebDec 21, 2024 · SUZHOU, China, Dec. 21, 2024 /PRNewswire/ -- CStone Pharmaceuticals (the "Company" or "CStone") is pleased to announce that the National Medical Products Administration ("NMPA") of China has approved the new drug application ("NDA") of anti-PD-L1 monoclonal antibody Cejemly ® (sugemalimab) in combination with … fitbit raise to wakeWebFeb 17, 2024 · CStone Pharma, a Suzhou oncology company, plans to raise $304 million in its Hong Kong IPO at a valuation of $1.5 billion (see story). Even though CStone is just two and one-half years old, it has ... fitbit rankingWebAlso Known As 基石药业, Jishi Yaoye. Legal Name CStone Pharmaceuticals Co., Ltd. Stock Symbol HKG:2616. Company Type For Profit. Contact Email [email protected]. Phone Number + 86- … fitbit range of productsWebJan 4, 2024 · Cstone Pharmaceuticals has announced the U.S. Food and Drug Administration’s (FDA) STUDY MAY PROCEED (SMP) letter and investigational new drug (IND) application approval for CS5001, a … fitbit range from phoneWebOct 12, 2024 · CStone Pharmaceuticals. Oct 11, 2024, 20:05 ET. SUZHOU, China, Oct. 11, 2024 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616) … fitbit rash refund 2022WebNov 22, 2024 · CStone Pharmaceuticals continues to expand its oncology presence aimed at the Chinese market. On Sunday, the company forged a licensing agreement with Jiangsu Hengrui Pharmaceuticals that grants the company access to a monoclonal antibody aimed at multiple forms of cancer.. Currently, the only anti-CTLA-4 monoclonal antibody that … fitbit rachatWebCStone Pharmaceuticals 6,317 followers on LinkedIn. 拓新药时代,筑健康基石 Lead the Era of Drug Innovation, Be the Cornerstone of Health CStone (HKEX: 2616) is a biopharmaceutical ... can garage band work with itunes